Effect of piperine on inhibition of FFA induced TLR4 mediated inflammation and amelioration of acetic acid induced ulcerative colitis in mice.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:

Piperine, a main component of Piper longum Linn. and Piper nigrum Linn., is a plant alkaloid with a long history of medicinal use. Piperine exhibits antidepressant, hepatoprotective, anti-metastatic, anti-thyroid, immunomodulatory, antitumor and anti-inflammatory activities, However its therapeutic potential in amelioration of ulcerative colitis and the underlying mechanism for anti-inflammatory activity remains unknown.The objective of the present investigation was to unravel the therapeutic potential of piperine on amelioration of IBD using acetic acid induced experimental animal model for ulcerative colitis and to determine the role of TLR4 receptor in signalling pathway of inflammatory gene expression in ulcerative colitis.

MATERIALS AND METHODS:

We induced colitis using acetic acid (150µl of 5% once, intrarectally) in mice and estimated disease activity index (DAI), which took into account weight loss, stool consistency, and occult/gross bleeding. Colon length, spleen weights, ulcer area and ulcer index were measured; histological changes were observed by H&E staining. Effect of piperine on various antioxidant parameter of mice colon such as tissue myeloperoxidase (MPO) accumulation, SOD concentrations, reduced GSH and lipid peroxidation were determined. Pro-inflammatory mediators, namely, nitric oxide (NO), tumour necrosis factor-α (TNF-α) were determined by a TNF-α ELISA kit obtained from Thermo fisher scientific India Pvt. Ltd. Effect of piperine on haematological parameters of mice in acetic acid induced IBD was also determined which involves the estimation of FFA using a commercial free fatty acid fluorometric assay kit.

RESULT:

Piperine significantly attenuated acetic acid induced DAI score which implies that it suppresses weight loss, diarrhoea, gross bleeding and infiltration of immune cells. Piperine administration also effectively and dose dependently prevented shortening of colon length and enlargement of spleen size. Histological examination indicated that piperine reduces oedema in sub-mucosa, cellular infiltration, reduced haemorrhages and ulceration as compare to acetic acid induced colitis in mice. Furthermore piperine inhibited abnormal secretion of pro-inflammatory mediators namely NO, cytokines TNF-α and reduces FFA induced TLR4 mediated inflammation.

CONCLUSION:

These results suggest that piperine has an anti-inflammatory effect at colorectal sites that is due to down- regulations of the productions and expression of inflammatory mediators and it also reduces FFA induced TLR4 mediated inflammation. Thus it may have therapeutic potential on amelioration of IBD.

• Authors: Rohit A Gupta, Meha N Motiwala, Nitin G Dumore, Kishor R Danao, Anjali B Ganjare
• Journal: Journal of ethnopharmacology (J Ethnopharmacol) Vol. 164 Pg. 239-46 (Apr 22 2015) ISSN: 1872-7573 [Electronic] Ireland
• PMID: 25683300 (Publication Type: Journal Article)
• Copyright: Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Chemical References

• Alkaloids
• Anti-Inflammatory Agents
• Benzodioxoles
• Fatty Acids, Nonesterified
• Piperidines
• Polyunsaturated Alkamides
• Tlr4 protein, mouse
• Toll-Like Receptor 4
• Tumor Necrosis Factor-alpha
• Nitric Oxide
• Malondialdehyde
• Superoxide Dismutase
• Glutathione
• Acetic Acid
• piperine

Topics

• Acetic Acid
• Alkaloids (pharmacology, therapeutic use, toxicity)
• Animals
• Anti-Inflammatory Agents (pharmacology, therapeutic use, toxicity)
• Benzodioxoles (pharmacology, therapeutic use, toxicity)
• Colitis, Ulcerative (chemically induced, drug therapy, metabolism, pathology)
• Colon (drug effects, metabolism, pathology)
• Fatty Acids, Nonesterified (blood)
• Glutathione (metabolism)
• Lipid Peroxidation (drug effects)
• Male
• Malondialdehyde (metabolism)
• Mice
• Nitric Oxide (metabolism)
• Piperidines (pharmacology, therapeutic use, toxicity)
• Polyunsaturated Alkamides (pharmacology, therapeutic use, toxicity)
• Superoxide Dismutase (metabolism)
• Toll-Like Receptor 4 (metabolism)
• Toxicity Tests, Acute
• Tumor Necrosis Factor-alpha (metabolism)